人TOP2A单克隆抗体的制备与初步应用

来源 :免疫学杂志 | 被引量 : 0次 | 上传用户:asdf303
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的制备抗TOP2A(DNA拓扑异构酶Ⅱ型α)单克隆抗体并对其生物学特性进行鉴定。方法应用分子生物学技术构建含人TOP2A编码序列的原核表达载体,表达并纯化人TOP2A蛋白。TOP2A蛋白皮下多点和腹腔注射加强免疫Balb/c小鼠,取脾与小鼠骨髓瘤细胞SP2/0进行融合,利用间接ELISA方法筛选杂交瘤细胞,采用有限稀释法进行亚克隆,用免疫印迹法、免疫组化染色和流式细胞术对抗体进行特异性鉴定。结果获得了3株能够稳定分泌TOP2A单克隆抗体的杂交瘤细胞,分别命名为11G5、3B10和10A3,通过免疫印迹、免疫组化和流式结果验证均为阳性。结论成功制备TOP2A单克隆抗体,为进一步的TOP2A蛋白的表达与肿瘤的关系研究奠定了基础。 Objective To prepare anti-TOP2A (DNA topoisomerase type Ⅱ α) monoclonal antibody and to identify its biological characteristics. Methods The prokaryotic expression vector containing human TOP2A coding sequence was constructed by molecular biology technique, and the human TOP2A protein was expressed and purified. The BALB / c mice were immunized with TOP2A protein subcutaneously and intraperitoneally. The spleen was fused with mouse myeloma SP2 / 0 cells. The hybridoma cells were screened by indirect ELISA and subcloned by limiting dilution. The antibodies were specifically identified by immunohistochemical staining and flow cytometry. Results Three hybridoma cells that could secrete TOP2A monoclonal antibody were obtained and named as 11G5, 3B10 and 10A3, respectively. All of them were positive by immunohistochemistry and flow cytometry. Conclusion The TOP2A monoclonal antibody was successfully prepared, which laid the foundation for further research on the relationship between the expression of TOP2A protein and tumor.
其他文献
目的应用PDCA质量管理体系,提高新生儿重症监护室(NICU)工作人员手卫生依从性。方法通过现场调查和暗访的方式对工作人员手卫生质量进行了调查与分析。结果运用PDCA循环质量
白血病是一种异质性疾病,患者间由于遗传特征的不同治疗结果差异较大.所以,确定提高诊断水平、改善治疗效果和实施个体化治疗的预测因子一直以来均为白血病研究的热点。
患者男,57岁,2004年12月,无诱因出现活动后气短,在当地医院行超声心动图示:左心房肿物,于2005年2月1日入院.发病以来,无发热、乏力、体重下降.既往:1989年行甲状腺腺瘤摘除术.吸烟20年,40支/d.体格检查:无阳性发现。